Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review.
Silverberg JI, Boguniewicz M, Quintana FJ, Clark RA, Gross L, Hirano I, Tallman AM, Brown PM, Fredericks D, Rubenstein DS, McHale KA.
Silverberg JI, et al. Among authors: rubenstein ds.
J Allergy Clin Immunol. 2024 Jul;154(1):1-10. doi: 10.1016/j.jaci.2023.12.013. Epub 2023 Dec 27.
J Allergy Clin Immunol. 2024.
PMID: 38154665
Free article.
Review.